The new product contains a combination of Omega-3s, toxin binders and antioxidants which the company claims flush out toxins, aid blood flow to the kidneys and maintain kidney architecture.
Matthew Shaw, Managing Director of nutravet said: "We’re really excited to launch nutraren, it’s a product our team have been working on for some time to make sure we have developed the best renal product for vets to recommend to their clients.
"Using independent trial data, we’ve been able to develop a unique formulation for nutraren containing 100% natural ingredients to benefit a pet’s long-term kidney health."
Authorised veterinary practices can now order nutraren from nutravet.
For more information, contact nutravet on 0845 604 1688, visit: www.nutravet.co.uk or email: info@nutravet.co.uk.
The companies are encouraging the use of CT to direct early, targeted surgical intervention and improve outcomes.
Dr Dean Felkler, Founder and CEO of Exotic Vet Support and senior clinician at Tai Wai Small Animal and Exotic Hospital in Hong Kong, says a recent case of his highlights the importance of accurate and early diagnosis.
A 7yr old rabbit was presented for anorexia and hadn’t passed faeces for over 12hrs.
Dean said: “A full diagnostic investigation was performed.
"From the radiographs it is difficult to appreciate the GDV.
"However, on the CT scan, reported by VetCT, it was very obvious when compared to the normal stomach orientation.”
After initial stabilisation the patient underwent surgery to re-orientate the stomach and an incisional gastropexy was performed.
Following surgery the rabbit recovered well and was eating and passing faeces within 24 hours.
Dr David Reese, Director of VetCT Australia and exotics expert said: “We are able to identify several life-threatening pathologies much more accurately with CT than radiographs.
"This is vital for early correction of acute surgical abdominal conditions to increase the likelihood of a positive outcome.”
VetCT is offering a free trial of its specialist teleradiology and teleconsulting services at: www.vet-ct.com
Photo: VetCT report of a CT scan showing GDV in a rabbit - The pylorus (lime green star) denoted by the thick pyloric wall is located on the left side of the abdomen and the fundus (dark pink star) is right laterally located.
The two-month campaign is comprised of a series of very polished videos which are now being shared on YouTube.
The videos share the experiences of a number of veterinary professionals from PSS practices who talk to the camera first as owners themselves, and then as vets.
The College says the aim is to demonstrate to the public that their animals will receive veterinary care from empathetic practice teams committed to delivering the kind of veterinary care they would want for their own animals.
Mandisa Greene, Chair of the Practice Standards Group, said: "In order for a veterinary practice to be accredited under the Practice Standards Scheme it needs to demonstrate that it is meeting a broad range of stringent standards and undergo a rigorous independent assessment every four years.
"However, we know that awareness and understanding of the Scheme amongst animal owners is relatively low, and that there is always more we can do to help change this. We have therefore developed this digital campaign to help RCVS-accredited practices explain to animal owners what RCVS-accreditation means, and why they should care about it.
"We think it’s important that RCVS-accredited practices, which go through a great deal of effort and work to achieve their accreditation, receive the recognition they deserve and we hope that they will help us to spread the word far and wide."
Ian Holloway, RCVS Director of Communications, said: “A vital ingredient of this campaign will be the support and involvement of RCVS-accredited practice teams right across the country. Throughout the two-month campaign, we will be posting lots of wonderful video stories, pictures and PSS infographics across all of our social media channels, along with other fun ways to help spread the word.
"We’re posting launch packs to all accredited-practice premises this week, which include a variety of campaign posters to display in waiting rooms and details of how to download all the digital resources from our campaign website for use in practice and online.
"We really hope that everyone associated with an RCVS-accredited practice, including their clients, will be able to share this campaign across their own channels as widely as possible, remembering to use the campaign hashtag #YourKindOfVets, of course!"
Anyone wanting more information about the campaign should email: yourkindofvets@rcvs.org.uk.
Stewart Halperin (pictured right), the vet who founded CarefreeCredit, said: "We originally started out by helping vets provide loans to treat pets needing medical attention which wasn’t covered by insurance, allowing them to provide the care needed, while also being paid immediately, improving cash flow and reducing bad debts.
"With this new service, vets can make their services better known in their local communities, which will also boost their turnover and allow them to care for even more animals."
Practices that use CarefreeCredit are given access to an online application process that takes around five minutes, providing loans from £250 upwards for use against any veterinary bills.
A range of credit terms are available from 0% APR upwards. They are also the only company to offer loan rates based on risk, which they say means more clients are likely to be accepted for finance.
CarefreeCredit practices that want to use the PR service need to contact the company, whereupon they'll arrange for an award-winning public relations consultant to provide the support they need - free of charge.
For further information, visit: www.carefreecredit.co.uk or call 0345 313 0177.
The BVA is also calling on Government to tighten pet import rules.
The advice follows news about a positive Brucella canis test in a rescue dog imported from Belarus in March this year.
The woman fostering the dog was hospitalised after coming into close contact with it, in the UK’s first confirmed dog-to-human transmission.
The foster animal and four pet dogs who were exposed to the disease, three of whom also tested positive, all had to be euthanised.
Data released by the Government shows a steep rise in confirmed Brucella canis cases since the start of 2020, rising from just three before that year to 107 till July this year.
The dogs were all either imported, had returned from holiday overseas, or been bred with an imported dog.
BVA is asking veterinary teams to:
British Veterinary Association President Justine Shotton said: “This recent case of Brucella canis in a foster dog is extremely tragic and highlights why vets have long raised concerns over the real and serious risks of importing ‘Trojan’ rescue dogs with unknown health histories into the UK.
“We know there is an added public health risk too, including for veterinary teams who treat and handle these animals, from contact with an infected dog’s contaminated body tissues and fluids.
"BVA continues to call on the Government to take urgent action to introduce stricter pet import measures, including mandatory pre-import testing, so we can minimise the spread of Brucella canis and other emerging diseases.
"We are also calling for the strengthening of enforcement provisions and checks on dogs brought into the country through the commercial route."
The 2021 B. canis risk view and statement by Public Health England (now UK Health Security Agency) contains vital information and recommendations for veterinary professionals: here:https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/960013/20210210_Brucella_canis_statement.pdf
BVA’s recommendations on tightening pet travel legislation: https://www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Policies/Companion_animals/BVA%20Position%20on%20Pet%20Travel%20Full.pdf
In a statement, the company explained that elevated vitamin D can cause vomiting, loss of appetite, increased thirst, increased urination, excessive drooling, and weight loss. At high levels, it can lead to serious health issues in dogs including renal dysfunction.
The company is inviting 'pet parents' (dear god, spare me) whose dogs are suffering symptoms after eating the products to contact their veterinary surgeon.
Hill's also says it will cover the cost of testing total calcium, albumin and 25OH-Vitamin D3 metabolites in animals which have consumed affected products, at the VitDAL Lab at the Edinburgh Veterinary School.
The affected products are:
In 2014 ioLight co-founders, Oxford physicists Andrew Monk and Richard Williams, filed a patent application for a pocket-sized digital microscope with a performance that compares with expensive laboratory microscopes. They asked Cambridge Industrial Design to realise the product, briefing them that the device would need to deliver images with one micron resolution (required to view human or animal cells) onto a smartphone or tablet, be pocket-sized, easy to use, and economical to build in medium to high volumes.
One of the biggest challenges was in making the unit pocket-sized, which meant it had to be foldable, something which could have led to a loss in the rigidity needed to achieve high resolution images. This challenge was overcome with the use of a single hinge which the company says makes the ioLight both portable and robust.
Alex Jones, Managing director of Cambridge Industrial Design said: "We recognised immediately this was a great idea but the design brief was certainly a challenge. Fortunately, challenges can sometimes bring out the best in designers. The final design is a real success both aesthetically and ergonomically, and this award is a fantastic acknowledgement for the design process and the final product that we have created together with ioLight."
ioLight is also celebrating another success: closing its second round of equity funding after raising £320k from 335 investors on the Crowdcube platform (128% of the initial target).
The company says the new funding will allow it to promote the microscope to a wide range of target markets including veterinary surgeons, education, laboratory and field research, museums and public engagement as well as to international markets.
Andrew Monk, ioLight’s co-founder said: "The product is so simple to use that it is the ideal communication tool for explaining science to the public, students and customers. The microscope lets everyone see the same image so the discussion is about the picture not the tools. It’s a perfect fit for government public engagement campaigns, which are well funded at the moment. We are absolutely delighted that this funding provides us with the opportunity for both product development and to reach out and make microscopy available to so many more people."
Miss Johnson was convicted at North Somerset Magistrates’ Court following a guilty plea of the offence of theft by employee in December 2023, after she stole buprenorphine belonging to Yatton Vets earlier that year.
She was sentenced to a fine of £120, a surcharge of £48, and costs of £85.
There were four further charges against Miss Johnson.
Charge one related to Miss Johnson stealing 5ml of methadone in December 2022 from her employer, Vets4Pets in Bristol, and injecting herself with the methadone.
The police investigated the incident and Miss Johnson accepted a conditional caution for the theft, the condition being she should attend a drug awareness course.
Charge two related to Miss Johnson dishonestly taking a syringe of methadone in August 2023 from her employer, the Langford Small Animal Hospital, and injecting herself with it.
Charge three related to two dates in September 2023 when she dishonestly took methadone, gabapentin and buprenorphine from Yatton Vets, her then employer, injecting herself with the buprenorphine and then working when unfit to do so.
Miss Johnson was later convicted of theft in relation to the buprenorphine (charge five).
Charge four related to an incident in November 2023, when Miss Johnson dishonestly took a syringe of buprenorphine from Bristol PDSA, for the purposes of self-administration, and was dishonest both to other members of staff and in the clinical records about the circumstances of taking the buprenorphine.
Charge five was in relation to Miss Johnson’s criminal conviction.
At the outset of the hearing, Miss Johnson admitted all charges in their entirety.
Having reviewed all the evidence and taken Miss Johnson’s admissions into account, the Committee found each of the charges proved.
After the criminal proceedings had finished and had been reported to the College, Miss Johnson wrote a letter expressing her deepest apologies to both the RCVS and the profession.
Within this she also made it clear that she took full responsibility for her actions.
In a later statement, she added that she had tried to use the experience to learn and improve in every aspect of her career and life and did not want to defend her behaviour.
Within this statement she also retracted a previous request to resign from the register, stating that she would accept any outcome to the investigation.
In deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account:
The Committee identified no mitigating factors and concluded that for each of the individual charges Miss Johnson’s conduct fell far short of the conduct expected of a member of the profession and that each of the charges one to four amounted to serious professional misconduct.
In relation to charge five, the criminal conviction, the Committee noted that the nature and the circumstances of the offence involved dishonesty, abuse of her professional position regarding access to controlled drugs, breach of her employer’s trust, and that the misconduct took place notwithstanding an investigation by the police for similar conduct in December 2022.
The Committee therefore concluded that charge five rendered Miss Johnson unfit to practise.
When deciding on a sanction, the Committee took into account mitigating factors, which included:
The Committee found no further aggravating factors at this stage.
Kathryn Peaty, chairing the Committee and speaking on its behalf said: “The Committee considered that the overall misconduct proved so serious and was incompatible with remaining on the register.”
She added: “The Committee accepted that Miss Johnson was currently likely to be drug-free on the basis of her evidence and that of her referee, but it noted that independent testing proving she had been drug free for any period of time was not available to it.
"Furthermore, Miss Johnson had been unable to demonstrate that she had worked without any incident recently as she had accepted she had been dismissed from her recent job.
“Having taken into account all of the aggravating and mitigating factors, and balancing the public interest and the need to uphold and maintain standards within the profession, and having decided that Miss Johnson’s insight was limited, the Committee concluded that the sanction of ‘removal’ was the only proportionate sanction it could impose in this case.
"It also decided that such a sanction maintained public confidence in the veterinary profession, safeguarded animal welfare and protected the public from any future risk of repetition of similar behaviour.
“The Committee therefore directed that the Registrar remove Miss Johnson’s name from the register of veterinary nurses forthwith.”
Lynn Jo Ann Davies MRCVS first appeared before the Committee in January 2018 to face a number of charges related to two drink-driving offences, breaching the terms of her undertakings to the College as part of its Health Protocol, and being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016.
Dr Davies admitted all five charges against her and admitted that this meant she was unfit to practise veterinary surgery and that she was guilty of disgraceful conduct in a professional respect. The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
At its first hearing the Committee having considered both aggravating and mitigating circumstances decided to postpone the hearing for six months on the basis of Dr Davies’ entering into a new set of undertakings, including one not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement.
At the second hearing, in July 2018, the Disciplinary Committee resumed its sanction inquiry decision. Dr Davies’ Counsel submitted on her behalf that Dr Davies wished to return to practise and the Committee reviewed her witness statements, documentary proof and medical records that she provided to demonstrate she had complied with the her undertakings given at the last hearing.
Stuart Drummond, Chairing the Committee and speaking on its behalf, said: "Having had the opportunity to see and hear from the respondent when she gave evidence and when she answered the questions put to her, the view formed of her current state of health was favourable. All members of the Committee considered that the account she gave of herself in the witness box was confident and they were reassured by her evidence as to how she now sets about managing her levels of stress and how she reacted to stressful incidents.
"Such concerns as the Committee had about her return to practice concerned her ability to receive support from a third party who would act as a mentor…the Committee therefore requires the Respondent to identify, within a period of one month of today’s date, a veterinary surgeon who would agree to act as her mentor. That mentor would have to be a veterinary surgeon acceptable to the College as someone suitable to act in that capacity and that mentor would have to be approved before the Respondent could resume practice.
"A further requirement of the Committee would be that the Respondent should make a disclosure to any new employer of the fact of her appearances before this Committee in January 2018 and in July 2018 and of the decisions of the Committee in relation to both such hearings. The final requirement of the Committee in this respect is that the respondent should not accept a 'sole charge position' at any time during her employment during this next period of postponement of sanction."
The Committee directed that the hearing be postponed for a further 12 months.
The survey was conducted by Mo Gannon & Associates, which asked 2,000 UK adults about their satisfaction with the service they and their animals received from veterinary surgeons, levels of trust in the profession, and whether the service provided by vets represents value for money.
32% of the respondents felt that veterinary surgeons represented excellent (8%) or good (24%) value for money. 38% thought that veterinary fees are fair. However, 29% thought that veterinary surgeons and their services provided poor (21%) or very poor (8%) value for money. The results were very similar to the last time the survey was conducted, in 2015.
Nevertheless, veterinary surgeons continue to enjoy very high levels of trust amongst the public. 94% said they either completely trust (34%) or generally trust (60%) vets. This put veterinary surgeons in third place amongst the most trusted professions, below opticians and pharmacists but above GPs and and dentists.
Satisfaction with the profession was also high. 80% said they were either very satisfied (39%) or satisfied (41%), putting vets in fourth place below opticians, pharmacists and dentists, but above general practitioners and accountants.
RCVS President Dr Niall Connell, pictured right (would you trust this man?) said: "These results clearly demonstrate that there is a great deal of good will towards the veterinary profession and the work they do in treating the nation’s animals and serving their communities. The basis of all good relationships is trust, and it is fantastic to see that our clients continue overwhelmingly to trust our knowledge and expertise and remain very happy with the service we provide them.
"The picture on value for money is clearly a bit more mixed, although clearly 70% of the respondents recognise that we at least charge fair fees in terms of our time and expertise. There is, of course, always more work that we can do in order to help the public understand veterinary costs and fees and promote the value of veterinary care, as demonstrated by last year’s joint Pets Need Vets social media campaign with BVA, in which we highlighted the benefits to pet owners of being registered with a vet."
The app, which has been accredited by the Association of Veterinary Anaesthetists, contains information about 36 different drug molecules in 10 different drug classes, including analgesics (NSAIDs, opioids and local anaesthetics), sedatives (acepromazine, alpha-2 agonists and benzodiazepines), induction agents, volatile agents, neuromuscular blocking agents, anti-cholinergics, sympathomimetics and antagonists where applicable.
It also offers 24 different dog and 15 cat anaesthetic protocols for procedures carried out in general practice. Each contains information on specific anaesthetic considerations for that condition or patient, any preoperative stabilisation required, premedication, perioperative analgesia, induction, maintenance and recovery.
Additional features include a dose calculator, summary sheets that can be saved or emailed to be attached to the patient’s clinical notes, and the option to save favourite protocols for repeated use.
The app was developed with the advice of two diplomat anaesthetists, Matthew Gurney BVSc CertVA PgCertVBM DipECVAA MRCVS and Joost Uilenreef DVM MVR DipECVAA, together with Elizabeth Barker BVetMed(Hons) Cert AVP(VA) PgCert MRCVS at Dechra.
Dechra Brand Manager Claire Morgan said: "We are passionate about anaesthesia and the provision of excellent support for vets, nurses and students. The app can be used to build confidence and knowledge in less familiar procedures or to update protocols to ensure best anaesthetic practice for the more common routine procedures.
"All of the protocols and information particularly emphasise considerations around anaesthesia, patient monitoring and perioperative analgesia, including local and regional techniques."
She added: "We hope the app will help practitioners to move away from a ‘one protocol fits all’ approach and give them the confidence to tailor the protocols and medications chosen to the specific patient and condition they are treating and to generally improve the standard of anaesthesia and analgesia in small animal practice."
The Dechra Dog and Cat Anaesthesia App is available to download for iOS and Android devices. For more information, visit www.dechra.com/dcaa
To take part in the survey, which will take about ten minutes, visit: https://www.surveymonkey.co.uk/r/RepRIPorVIP.
Everyone who completes the survey will be entered into a draw to win one of three £50 Amazon vouchers.
The House of Lords debate, which is being hosted by Professor The Lord Tress of Kinross, will take place on Wednesday, 21st June 2023.
Speakers will include Donal Murphy of NOAH, Rita Dingwall of the Federation f Independent Veterinary Practices and Paul Horwood, Country Head of Farm at IVC Evidensia.
https://vma.org.uk/house-of-lords/
Inigo’s abstract entitled “Predictive value of cardiac remodelling on survival in dogs with persistent atrial standstill – the UK perspective” sought to determine the survival of dogs in the United Kingdom with persistent atrial standstill (PAS) after pacemaker implantation and the prognostic value of cardiac remodelling. The Congress Programme Committee were impressed by Inigo’s innovative presentation, praising the planning and execution of the multi-centre project.
Ditte’s presentation was entitled “Evaluation of a point-of-care dot Enzyme-Linked Immunosorbent Assay to detect antibodies against canine parvovirus, distemper virus and adenovirus before revaccination”.
Her study described the findings of a prospective non-inferiority study of a point-of-care semi-quantitative titer test performed on canine serum samples and compared to gold standard analysis. Sensitivity, specificity, positive and negative predictive values of the point-of-care titer test were determined for the gold standard titer cut-offs for canine adenovirus, canine distemper virus and canine parvovirus. Ditte was commended by the Congress Programme Committee for the quality of presentation as well as the practical and clinically applicable findings of the study.
The BSAVA Congress Clinical Abstracts, including the winners’ abstracts, are now available to view in the BSAVA Library here: https://www.bsavalibrary.com/content/book/10.22233/9781913859039.
Virbac Animal Health has launched CaniLeish, the first vaccine for canine leishmaniosis in the European Union.
Leishmaniosis is a vector-borne parasitic disease caused by infection with protozoa of the genus Leishmania (L infantum in Europe). Leishmaniosis is transmitted by the bite of infected sandflies. In south-western Europe 2.5 million dogs are believed to be infected1,2 with the parasite and the disease is spreading northwards,3 as more people travel with their dogs or import infected animals from endemic areas.4 So far preventative methods have been limited to reducing the habitat of sandflies, minimising the physical contact of dogs with sandflies and using insecticides on dogs (sprays, spot-ons, repellent-collars, etc).
According to Virbac, CaniLeish's ability to protect dogs was demonstrated in an experimental challenge study, where the benefit of vaccination was still evident after one year.5 In an extreme condition natural challenge trial lasting two years under environmental conditions rarely encountered in reality, 93% of dogs vaccinated with CaniLeish did not develop symptomatic leishmaniosis. CaniLeish provides a fourfold reduction in the risk of developing this fatal disease. 6 Its safety profile has been shown in laboratory testing and field trials.7 In addition, Virbac says it contains no whole parasites that could be virulent in any host.
David McGahie BVMS Bsc (VetSci) MRCVS, Medical Department Manager at Virbac SA, said: "The development of this vaccine is a key milestone in the battle against this challenging disease which is a major problem in many regions of the world. Although in the past it was considered a rather exotic disease here in the UK, the advent of the Pet Travel Scheme means it has become increasingly important as a problem for dogs which regularly travel abroad to endemic regions."
CaniLeish can be given to dogs as young as six months of age: the primary course consists of three injections given over six weeks. Dogs should be re-vaccinated annually, with a single dose administered one year after the third injection and annually thereafter.
References:
Brian (pictured right), said: “I am absolutely delighted that Colourful CPD has joined Agilio and I see this as a win-win-win for Colourful CPD, Agilio and the veterinary profession.
"Colourful CPD’s courses complement Agilio’s vast array of existing statutory and mandatory courses which they already distribute within the UK as well as all around the world, thus enabling Colourful CPD to make the move up to the next level, both here and abroad.
I believe veterinary practices, as well as all the roles working within them, will benefit from being able to access a range of new courses and management services from Agilio.”
To mark its expansion into the veterinary sector, Agilio will be launching iTeam, its HR and rota software, together with iLearn, an online training and CPD accredited platform at the London Vet Show in November.
https://www.colourfulcpd.comhttps://agiliosoftware.com
A short film about Ami Sawran MRCVS, who simultaneously works as a vet, an actress and the editor of a lesbian magazine called Reprobait, is being released in Vue West End and Vue Piccadilly cinemas from today.
The film, being shown ahead of big screen blockbusters, is part of a series which make up 1000 Londoners, a project to create a digital portrait of the city.
Each film dips into the life of a Londoner for three minutes. The first ten films being shown over the next two months include one about an entrepreneurial hula-hooper from Hoxton, another featuring the last cloth trader in Shoreditch, one about a cage-fighter on the day of his first professional fight and another about a Big Issue seller who works on the Strand.
Rachel Wang, director of 1000 Londoners, said: “This release gives the people of London an opportunity to see these fascinating documentaries in the greatest way to watch any film in London – on the big screen in the West End. By making this possible Vue Entertainment have been extremely open and forward-thinking in their programming.”
The 1000 Londoners films are currently being released weekly on 1000londoners.com The latest film "Danny" looks below the city into Bazalgette's Victorian sewers, where professional 'flusher' Danny Brackley works. Forthcoming Londoners include an ex-SAS author, a third generation blacksmith from Stepney and a woman who has withdrawn from mainstream society to live on a canal boat.
The CAMadvocate course (http://www.cameducation.co.uk), which is delivered online, consists of 10 modules with video presentations, course notes, downloads, owner-focused tools, further online learning, and social media uploads.
The course is designed to help canine professionals improve their understanding of canine arthritis, and to define their role in the identification, diagnosis, and management of the condition.
Hannah Capon MRCVS, the founder of Canine Arthritis Management said: "Dog walkers, groomers, trainers, kennel owners, etc., are all influencers! They have the ability to support a long-term veterinary-derived management plan. Or they have the ability to destabilise it!
"Owners listen to these people because they have more available time; they may appear less like a business and more like a friendly service or even a peer; or they may offer advice that seems more convincing. Whatever the reason, we should harness their powers and ensure they are disseminating reliable information whilst servicing their own needs!"
Canine Arthritis Management believes that a multidisciplinary team is required to better manage this disease, that this includes professionals outside the veterinary practice, and by harnessing their influence, the profession can educate more owners, identify this disease earlier, action appropriate management plans and give owners more years with their pets.
Hannah added: "I hope the profession will support this initiative and consider applying it to other chronic diseases that are prone to misinformation due to lucrative product sales."
CommentA training course / qualification developed by a veterinary surgeon and designed to educate influencers. It's genius. Surely there's huge scope for this kind of initiative beyond canine arthritis? What do you think pet owners are most ill-informed about, where it could be really effective to better educate canine influencers, so that they in turn will pass it on. Post your thoughts here.
A 2012 RVC graduate, Daniella is the Principle Exotics Vet at ParkVet Hospital and is studying towards a certificate in Zoological Medicine. She said: "Despite their amazing work, the AWF struggles for funds to continue its vital work, so I have decided not only to be the first ever person to run the London Marathon for the AWF, but to run it in costume!
"Those who know me will be aware that running is not among my favourite activities, but I am stepping up to the challenge to raise much-needed funds for this fantastic charity that’s making a real, tangible difference to animals worldwide."
"Working full time in clinical practice, including being part of an out-of-hours rota, means training must be factored in with military precision: so far, some of my longer runs are planned for 4 am!
"I also entered the Hastings Half Marathon on 18 March, and my final training run prior to the big day is scheduled for when I will be in Queensland, Australia for my brother’s wedding.
"If I can manage 22 miles in those hot and humid conditions, the London Marathon should be a breeze!”
Chris Laurence. AWF Chair of Trustees, said: "I am delighted that Daniella has chosen to raise funds for AWF in what is arguably one of the biggest sporting events in the world. On behalf of the organisation, I’d like to thank her for her support and wish her all the best for the marathon."
To support Daniella’s fundraising, visit: https://uk.virginmoneygiving.com/DaniellaDosSantos
For updates on her training and to find out more about AWF, visit www.bva-awf.org.uk
A paper introduced by the RCVS Registrar Eleanor Ferguson looked at the possibility of the RCVS prosecuting, for example, unqualified individuals undertaking veterinary work and courses falsely purporting to lead to a registerable qualification.
The paper also explored other options, including better educating animal owners about veterinary services and assisting people with concerns about the breaches of the VSA to raise them with the authorities.
Council heard that over the past year, the RCVS had assisted other agencies on investigations of suspected VSA breaches on a number of occasions.
It was considered that the RCVS could consider undertaking its own private investigations and criminal prosecutions when statutory prosecuting authorities did not have the resources to pursue these cases.
However, the RCVS has no statutory powers of investigation, so if it did pursue a private prosecution, it would have no powers to carry out a criminal investigation or compel evidence.
Council members voted for a further paper setting out a draft policy on private prosecutions, as well as what general information regarding breaches of the Veterinary Surgeons Act could be provided to members of the public and the professions.
VetSurgeon.org has announced the launch of VetSurgeon Jobs, a new service designed to change the way veterinary surgeons are hired, saving veterinary practices hundreds, sometimes thousands of pounds.
Since 1761, when the veterinary profession first came into existence, employers have had no choice but to advertise job opportunities for veterinary surgeons and practice managers in magazines.
Editing, printing and publishing a magazine is an eye-wateringly expensive business, costs which have been reflected in the price advertisers have had to pay.
The Internet has brought those costs right down. Furthermore, in a survey of job seekers carried out last earlier this month by VetSurgeon.org, 70% said they spend most time browsing jobs online these days, as opposed to in a magazine.
However, when you look at the costs of advertising on websites published by veterinary magazine publishers, which start at £395 and quickly rise to £795 for a 28-day online advert, it is clear that these prices still reflect the considerable costs of magazine production.
Today, VetSurgeon.org launches it’s online-only job advertising service, priced simply at £99+VAT, which gets you a 60-day advert on the website most followed by UK veterinary surgeons.
That price doesn’t just offer a considerable saving over alternatives in the veterinary profession, it also beats the major online-only players outside the profession (including Monster, Reed and Totaljobs)
There’s more to it than just price, though. Unlike the alternatives, VetSurgeon Jobs is not an 'off-the-shelf' solution, but something designed from the ground up for the veterinary profession.
For jobseekers, VetSurgeon Jobs has been designed to make finding the right job as simple and straightforward as possible. Just enter the postcode and search radius, and the available jobs re-order by distance. You can subscribe to be alerted of only those jobs that meet your very specific criteria (such as locum positions within a given radius). Perhaps most importantly, VetSurgeon Jobs is an integral part of the thriving community on VetSurgeon.org. So you can add your CV to your online profile and then engage directly with employers on the site.
For employers, VetSurgeon offers the opportunity to publish a more engaging, interesting advertisement than is currently offered anywhere else, including maps, photos, logos and headline propositions.
Arlo Guthrie said: "It’s a cliche, but if ever there was a 'win-win' situation, this is it. I’m able to offer you the chance to save a small fortune, whilst making some for myself and to reinvest in yet more features designed to support your profession."
For more information, visit https://www.vetsurgeon.org/jobs/, ring 0207 183 2511 or email support@vetsurgeon.org.
And if you want to support our efforts ... please share this story using the links immediately below.
BVA President Malcolm Morley said: “Judging this competition has been genuinely both extremely enjoyable and really difficult.
"The entries this year have absolutely surpassed expectations and the level of talent on display is amazing.
"However, the photographs we have chosen are all well worthy of being finalists.
"From photos that made us laugh out loud, to others that made some of us feel close to tears, they evoked a range of emotions, but we were also impressed by the quality of the images, the creativity of the photographers and the composition of the photos, as well as the stories behind the lens.
The finalists are:
Vets at work
All creatures great and small
Happy pets that make us smile
The winners will be announced at BVA Live at Birmingham’s NEC in May, where this year there is also an opportunity for BVA Live delegates to vote for their favourite image from the shortlist, with a new ‘People’s Choice’ winner being announced in the weeks following the event.
Felpreva contains emodepside and praziquantel, with tigolaner, a novel bispyrazole active ingredient.
Felpreva is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections.
Vetoquinol points to a survey revealed conducted last year in which 43% of cat owners said that giving parasite protection to their cat makes them feel guilty, stressed, or worried1.
Felpreva provides an option to reduce the frequency of treatments, lessening stressful interactions between owners and their cats.
Vetoquinol says that with Felpreva’s convenience and longer-lasting flea and tick protection, it aims to help support compliance and thus improve the wellbeing of feline companions.
Helen Hunter, Senior Product Manager at Vetoquinol UK, said: “The launch of Felpreva is a truly proud moment for Vetoquinol, demonstrating our expertise, passion, and commitment to innovation in this essential category of companion animal medicine.
"It will allow us to safeguard the health of cats by bringing longer-lasting protection, convenience, and ease of use – for both pet owners and veterinary professionals.
"At a time when vets are treating more pets than ever before, the need for a breakthrough endectocide solution like Felpreva has never been greater.”
Felpreva is in wholesalers now.
For more information, contact your local Vetoquinol representative.
Reference
Eprecis injection (eprinomectin) is an broad spectrum endectocide with activity against gastrointestinal nematodes in sheep1 and goats2.
After Eprecis injection Haemonchus contortus in the abomasum in goats were reduced by 97.8%2 and Trichostrongylus colubriformis in the small intestine were reduced by 98.7%2.
In lactating dairy ewes Eprecis injection was found to be 99% effective against gastrointestinal nematodes3 and was associated with an increased milk yield of 8%4.
The bioavailability of eprinomectin after one Eprecis injection in goats is larger than that reported for eprinomectin pour on5, 6, with Eprecis injection found to be four times more efficacious than eprinomectin pour-on across four dairy goat farms7.
In sheep, the efficacy of Eprecis injection against gastrointestinal nematodes in sheep is 99.6% versus 86.1% for a pour-on formulation8.
Eprecis injection is associated with higher plasma levels of eprinomectin and has a higher efficacy compared to eprinomectin pour-on in dairy ewes naturally infected with gastrointestinal nematodes8.
This is also achieved using five times less active than a pour-on formulation8.
Eprecis injection is administered subcutaneously and there is no need to part the fleece or coat along the animal’s back.
Ceva says it has excellent syringeability9 and a low dose volume (0.1ml/10kg) to help with accurate dosing of animals.
Harry Walby, ruminant veterinary advisor at Ceva Animal Health, said: “Eprecis injection is a highly effective broad-spectrum wormer that is now available in sheep and goats, as well as cattle.
"The injectable formulation not only allows accurate dosing, but there is no subclinical dose transfer between animals.”
Eprecis injection is available in 100ml and 250ml CLAS vials.
References
Elanco Companion Animal Health has launched a new ordering process for Recuvyra, its transdermal fentanyl solution for the control of postoperative pain relief in dogs.
The new process will enable veterinary practices to purchase Recuvyra, which is a Schedule Two Controlled Drug, without having to complete the online training programme which was has been mandatory since the launch of the product in April 2013.
The company says that training is still highly recommended for every veterinary professional that handles Recuvyra due to its new delivery system. This can be via the short online training course available at www.recuvyratraining.eu or by reading the training leaflet provided with every vial of Recuvyra. The training leaflet includes information on instructions for use, correct administration of the product and special precautions. In addition, client leaflets and other support materials will continue to be available to vets via the website.
Alice Laurens, Recuvyra product manager at Elanco Companion Animal Health, said: "Veterinary practices will still need to follow their wholesalers' procedures for ordering Schedule Two Controlled Drugs when purchasing Recuvyra, however any vet from the practice can now order and sign for delivery of the product making it easier to purchase."
For further information about Recuvyra or Elanco's surgery and pain management range, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@elanco.com.
The RCVS Disciplinary Committee has dismissed charges of serious professional misconduct against a veterinary surgeon and former employee of Medivet (Watford).
Tomasz Nazimek, who qualified in Poland in 2001 before starting work in England in 2005, was alleged to have charged for the use of a blood pressure monitor during an exploratory laparotomy on a cat called Mitzi, whilst working at the Watford branch of Medivet in June 2009, when he knew, or ought to have known, it had not been used.
Despite his previous signed statements to the contrary, Mr Nazimek admitted at the outset of the hearing that no blood pressure monitor had in fact been used.
Accordingly, the Committee only had to establish whether Mr Nazimek himself had entered the fee for its use into Mitzi's records and, if so, whether this was done dishonestly.
The alleged incident came to light as a result of a covert investigation into Medivet conducted by the television production company Fulcrum TV in 2008/9, and subsequently commissioned by the BBC and broadcast in July 2010 as part of the Panorama programme 'It Shouldn't Happen at a Vets''.
Former dental nurse Alexandra Lee was employed by Fulcrum TV as an undercover reporter to work as a 'trainee veterinary nurse' at Medivet, in order to record audio and video footage of her experiences there.
The case against Mr Nazimek was based partly on a conversation overheard by Miss Lee following the operation on Mitzi, where she maintained that Guy Carter, a senior Medivet partner and veterinary surgeon, told Mr Nazimek (who was sitting at the practice computer typing up Mitzi's records) not to forget to include a fee for use of the blood pressure monitor.
However, Miss Lee's equipment had not recorded this exchange, due to a fault, and her video diary of that day's events was not put in evidence before the Committee. Miss Lee also accepted in evidence that she had not actually seen who entered the fee into the records, but had assumed it was Mr Nazimek.
Despite giving serious consideration to all of Miss Lee's evidence, the Committee found it of limited value.
The Committee considered the statements signed by Mr Nazimek, but prepared for him by the Medivet senior management in December 2009 and October 2010, which stated that he had used the monitor, consulted Mr Carter about charging for it and then added the fee himself.
The Committee also considered a third statement provided to the College (September 2011), in which Mr Nazimek recalled that Mr Carter had priced up the operation himself, but not asked for his input.
When questioned about the discrepancies in his statements, Mr Nazimek told the Committee that he had confused different operations and now knew his earlier statements to be wrong.
He indicated that he had been under pressure from his then employers to sign the statements, that his attempts to change them were ignored by Medivet's managing partners and that he was depressed and under stress at the time.
He was not told that the statements could be in relation to charges against him, or that he was entitled to legal advice when discussing them with his employers.
The Committee found Mr Nazimek's oral evidence to be persuasive, his manner open and his responses under cross-examination frank.
In the absence of satisfactory and reliable evidence to the contrary, and in view of supportive testimonials provided from his current employer and former colleagues as to his honesty and integrity, the Committee found Mr Nazimek's repeated assertion that he did not make a charge for the monitor "entirely plausible" and believed that he told the truth.
Nevertheless, the Committee emphasised that a charge for the monitor had been entered into the records when no such device had been used, which it regarded as unacceptable.
Speaking on behalf of the Committee, Chairman Professor Peter Lees said: "The Committee is not satisfied by the evidence so that it is sure that [Mr Nazimek] entered into the records for Mitzi a charge for the blood pressure monitor. [It] believes that [Mr Nazimek] told the truth when giving his evidence and the character references support his honesty.
"In these circumstances, it is not necessary to consider the charges further and the allegations against [Mr Nazimek] are dismissed."